| Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More | Frank Vinluan | 04/26/19 | National |
| Bio Roundup: A Gene Editing 1st, China Rises, Schenkein Steps Away | Ben Fidler | 09/07/18 | National |
| East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More | Ben Fidler | 12/05/14 | Boston |
| SurgaColl Aims to Fix Your Bones and Joints Without Drugs or Grafts | Ben Fidler | 10/30/14 | National |
| Histogenics Secures $10,323,988 New Financing | VentureDeal | 01/07/14 | Boston |
| Student Startups Cardiovate and Invictus Tackle Big Medtech Markets | Bernadette Tansey | 05/14/13 | Texas |
| Histogenics Brings In $49M for Tissue Regeneration—and Recapitalization | Gregory T. Huang | 07/24/12 | Boston |
| Histogenics Obtains $49,000,000 Series A Funding | VentureDeal | 07/24/12 | Boston |
| Histogenics Receives $49,000,000 Series A Round | VentureDeal | 07/24/12 | Boston |
